Checklist of recommendations for future randomized clinical trials, comparing the TEP with the Lichtenstein technique.

In an attempt to bridge the information gap a new trial should at least comprise as many patients as the hitherto largest and that preferably several new trials will be needed with at least as many patients as it takes to produce a boundary break through (boundary for benefit, harm or futility) in the TSA, or in the worst case scenario; to close the gap between the required and the presently accrued information size.